Summary: Nontuberculous mycobacterial infections are rare but severe complications of chemotherapy in children. In children with prolonged lymphopoenia after mieloablative regimens, symptoms can be nonspecific and fever and pulmonary impairment are the most common clinical features. Diagnosis is challenging for physicians and microbiologists and often requires invasive techniques. We report a girl affected by acute lymphoblastic leukemia, who developed a disseminated infection sustained by Mycobacterium avium complex. Identification of the microorganism was obtained by open lung biopsy and evidence of mycobacterium genome. We also reviewed 15 literature cases of disseminated infections of nontuberculous mycobacterium in children with leukemia.
I
n children, infections sustained by nontuberculous mycobacteria (NTM) are signaled. The spectrum of infections includes single-organ localizations as seen in the immunocompetent host, upto visceral dissemination in immunocompromized children. Chemotherapy for the treatment of malignancies can expose to NTM infections. In daily clinical practice, the diagnosis of NTM infections is rarely suspected. The microorganisms are difficult to timely isolate and often produce nonspecific symptoms of mycobacterium infection. 1 Moreover, once mycobacterial etiology is suspected, typical tubercular mycobateria are still commonly investigated, causing delays in diagnosis. Indeed, reports about infections sustained by NTM in children with cancer are rare. We reviewed 15 cases 2-10 of disseminated infections sustained by NTM in children with leukemia present in the literature. Moreover, we report an additional case of life-threatening pulmonary infection sustained by NTM in a girl undergoing chemotherapy for leukemia, which completely resolved with no further recurrence.
CASE REPORT
A human immunodeficiency virus-negative 11-year-old girl affected by intermediate-risk acute lymphoblastic leukemia underwent chemotherapy according to the Italian Association of Pediatric Hematology and Oncology (AIEOP) protocol. During the first maintenance regimen (daily oral 50 mg/sqm mercaptopurine and weekly oral 20 mg/sqm methotrexate), she suffered severe chemotherapy-related lymphopoenia (< 300/mm 3 ) with high fever and cough. A computed tomogtaphy (CT) scan (Fig. 1A) detected multilobar lung involvement, consisting of multiple nodules with mediastinal and abdominal lymphadenopathies. Bacterial, viral, and fungal cultures were performed on biological stools, resulting negative. Peripheral blood and central venous catheter (CVC) haemocultures were negative, allowing the elimination of the suspicion of a bloodstream infection. The patient was anergic to the Mantoux test. Chemotherapy was then stopped and empirical intravenous wide-spectrum antibiotic therapy was started, with persistence of fever. Partial benefit without complete defervescence was obtained after introduction of clarithromycin and voriconazole in the antibiotic schedule. Infections due to tuberculous or atypical mycobacteria were excluded from the samples of blood, sputum, urines, and cerebral spinal fluid by microbiological tests and polymerase chain reaction (PCR). Moreover, bone marrow examination was negative for infections. Bronchoalveolar lavage and lung fine needle aspiration were also performed and showed nonspecific inflammation; microbiological exams did not reveal acid-fast organisms and cultures were negative. After 20 days of intravenous antibiotic therapy, the patient was apyretic and minimal radiologic improvement was evident, therefore, she continued administration of oral voriconazole at home. A month later, voriconazole was stopped and chemotherapy was restarted, and a second induction regimen without steroids (doxorubicin, cytarabine, cyclophosphamide, vincristine, and intrathecal methotrexate) was completed. One month after the start of the following maintenance phase, the patient suffered long-lasting pancytopenia and fever, and chemotherapy was finally interrupted. Other cultural investigation of biological samples and CVC haemocultures were promptly performed and resulted negative for infections. For the persisting fever, the CVC was removed but no microorganisms were found on the device. Repeated bone marrow aspirate confirmed leukemia remission but the biopsy disclosed a bone marrow granulomatous inflammation. The patient suffered sudden respiratory distress that required hospitalization in intensive care unit for orotracheal intubation and mechanical ventilation. A pulmonary CT scan documented a diffused bronchial thickening and bilateral infiltrates with excavations (Fig. 1B) .
Three deep bronchial aspirates were repeated on different days while the patient was intubated, PCR and cultures were negative for mycobacteria. On suspecting lymphomatous granulomatosis, steroids were administered (dexamethasone 80 mg/ sqm/d), obtaining rapid respiratory improvement and apyrexia. An open lung biopsy (OLB) was then performed documenting pulmonary granulomatous inflammation and caseous necrosis. Steroids were rapidly interrupted and antimycobacterial multidrug treatment was introduced, with intravenous isonyazid 6 mg/kg/d, ethambutol 15 mg/kg/d, rifampin 15 mg/kg/d, and amikacin 15 mg/ kg/d until negative results of microbiological tests were obtained.
Tissue culture of OLB did not reveal mycobacterial infections. Finally, PCR documented the genome of Mycobacterium avium complex (MAC) on samples of lung biopsy. Isonyazid, rifampin, and amikacin therapy were promptly stopped and the antimicrobial schedule was shifted to intravenous clarithromycin 15 mg/kg/d, with further respiratory rapid improvement upto extubation. Clarithromycin and ethambutol were further continued for a 3-month period; following, the patient was treated for 6 more months with oral ciprofloxacin 10 mg/kg/d at her domicile. Radiologic follow-up documented gradual resolution of the pulmonary and mediastinal involvement (Fig. 1C) . The granulomatous inflammation disappeared from bone marrow after 6 months of antibiotic treatment. Chemotherapy was never restored, despite any other evidence of mycobacterial infection. At present, the patient shows complete remission of her leukemia, after 7 years from the diagnosis. Pneumological follow-up documented progressive improvement of the respiratory function, without disabling restrictive pattern persisting to the spirometry.
DISCUSSION
During the last years, NTM have been isolated with increasing frequency. 1 However, there are only a few pediatric reports of infections sustained by microbiologically documented atypical mycobacterium in immunocompromized children. Normal CD4 levels deserve an essential role in the control of infection due to NTM, and prolonged lymphopoenia particularly predisposes to worsening infections. Clinical features are nonspecific: the most frequent presentations include lymphadenitis and prolonged fever, less commonly dyspnea and haemoptysis. In children undergoing chemotherapy for lymph-proliferative malignancies, NTM infections can rarely occur, complicating the program of treatment and worsening the prognosis; in this group of patients, NTM can produce severe pulmonary involvement and rapid disseminated infection.
In the literature, only 15 cases 2-10 of children with lymph-proliferative disease who developed NTM infections are reported, and different clinical presentations and sites of infections are summarized in Table 1 . Blood cultures are often revealing, as seen in 10/15 patients of our revised series who developed NTM bloodstream infections. 2, 3, 5, 6, 10 In 9/15 patients, 2,3,5,6,9,11 the CVC was removed for fever or NTM sepsis, and CVC was colonized in 6 patients. 2, 5, 6, 9 Lungs represent a primary site of infection, as noticed in 10/ 15 patients of the revised series 2-4,7-10 : MAC was the most common nontuberculous mycobacterial pathogen found in the lung, 2, 7, 8 and this data agrees with the literature. The radiologic findings in NTM infections, including MAC, are nonspecific, and possible presentations may vary between slowly progressive lung nodulations or bronchiectasis and fibrocavitatory lung disease leading to rapid respiratory failure. 1 Chest high resolution CT scan demonstrates thinwalled cavities with peripheral peribronchovascular pulmonary nodules, but none of these features is sufficiently specific to be diagnosed on the basis of the radiologic appearance. 12 In other cases, microbiological isolation of NTM in cultures from biological fluids can be difficult and definitive etiological diagnosis requires more invasive investigations. In our revised series, NTM disease was rarely documented by PCR on skin 4 or spleen biopsy. 6 In the suspicion of NTM lung disease, an OLB allowed histopathologic and microbiological diagnosis in 3/15 patients. 2, 8, 9 Moreover, in our report, an NTM infection sustained by MAC was recognized by lung tissue biopsy using PCR. In 2007, the American Thoracic Society outlined extensive guidelines for the clinical approach to NTM lung infection. 1 Diagnostic criteria for NTM lung disease in adults include Z2 separate sputum samples that grow NTM or 1 bronchial alveolar lavage specimen that grows NTM. These criteria are not validated in children, and published data currently indicate the value of other techniques for definitive diagnosis. PCR has emerged as a promising and useful tool in the clinical context of patients with suspicion of mycobacterial disease with negative results of standard microbiological tests. 13 Advantages of PCR are high sensitivity and specificity of probe, quick detection of bacteria from poor samples with low number of organism in <48 hours, and differentiation between tubercular and atypical mycobacterium infections. 14 Although PCR appears to be a promising diagnostic instrument, its role in the routine diagnosis of NTM infection is still uncertain and not standardized at present. In our experience, PCR could allow starting appropriate early treatment in our severely immunocompromized patient with life-threatening respiratory failure. Moreover, authors suggest that PCR should be routinely used for the mycobacterial identification in biopsies showing granulomatous reaction without demonstrable acidfast bacilli. 14 Indeed, infection sustained by NTM can produce aspecific granulomatous reaction, as demonstrated in our patient and in another case of the series, who developed bone marrow granulomatosis during a MAC infection. 13 In children, of the mycobacterial disease, other conditions have been implicated in the formation of bone marrow necrotizing granulomata, including tumors, viral, bacterial, and fungal infections, autoimmune diseases, drugs, and sarcoidosis. 15 In pediatric patients affected by leukemia, lymphomatoid granulomatosis is a rare cause of granulomatous inflammation involving both lungs and bone marrow 16 ; skin and central nervous system can also be concerned. This angiocentric and angiodestructive condition has characteristics of both a lymphoproliferative and a necrotizing aseptic granulomatous process and it is due to a combined lymphocyte B-cell and T-cell disorder caused by leukemia or its treatment. The evidence of an atypical lymphoproliferative infiltrate on samples from OLB or bone marrow biopsy can help the diagnosis and allow specific treatment with steroids-based lymphoma-directed therapy.
Several schedules of treatment are employed to contrast NTM infections in immunocompromized patients on the basis of combination of antitubercular drugs, macrolides, aminoglycosides, and chinolonics. International guidelines for therapy in adults with NTM lung infections, including MAC, have been published, recommending multidrug regimens with various combinations of clarithromycin /azithromycin, ethambutol, rifampicin with addition of amikacin/streptomycin. 1, 12 Unfortunately, definite management of therapy in immunocompromized children has not yet been formulated and the optimal regimen is yet to be determined. At present, no specific therapeutic approaches have been produced for children undergoing intensive chemotherapy or conventional maintenance regimens. Moreover, the duration of therapy for NTM infections is still not standardized, depending on host status, site of involvement, and severity. Most experts recommend a minimum of 3 to 6 months or longer. 17 For children with leukemia, the choice to continue the antimycobacterial therapy upto 12 months have to be balanced with the need to rapidly restore the schedule of chemotherapy. Our patient received treatment with clarithromycin and ethambutol for 3 months, following treatment with ciprofloxacin for 6 other months. Despite the premature stop of her chemotherapy schedule, the girl was persistently in complete leukemia remission after the resolution of her pulmonary infection. As in the case we reported, the outcome of most children with leukemia described in the literature was not modified by the NTM infection: 13 patients survived in complete remission and only 1 died of relapsing tumor. 6 Only 1 death was attributed to a MAC infection and occurred in a patient treated for acute myeloid leukemia who developed a severe pulmonary infection, detected by PCR on tissue from OLB. 10 In conclusion, NTM represent an important group of microorganism in research for the diagnosis of lifethreatening infections in pediatric patients with prolonged lymphopoenia under chemotherapy. For their unusual presentations and the potential rapid organ impairment, optimal diagnostic method must consider invasive techniques to isolate the microorganisms in deep biological samples. Prompt combination of supportive care and antimicrobial multidrug regimen can allow resolution of life-threatening infections and the completion of the chemotherapy program.
